JFFIX
Price
$33.33
Change
+$0.14 (+0.42%)
Updated
Jun 12 closing price
Net Assets
1.91B
VFFVX
Price
$72.96
Change
+$0.39 (+0.54%)
Updated
Jun 12 closing price
Net Assets
76.7B
Interact to see
Advertisement

JFFIX vs VFFVX

Header iconJFFIX vs VFFVX Comparison
Open Charts JFFIX vs VFFVXBanner chart's image
JFFIX vs VFFVX Comparison Chart in %
View a ticker or compare two or three
VS
JFFIX vs. VFFVX commentary
Jun 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JFFIX is a Hold and VFFVX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VFFVX has more cash in the bank: 76.7B vs. JFFIX (1.91B). JFFIX (1.91) and VFFVX (1.87) have matching dividends . JFFIX was incepted earlier than VFFVX: JFFIX (14 years) vs VFFVX (16 years). JFFIX (0.51) is less costly to investors than VFFVX (0.08). JFFIX is a more actively managed with annual turnover of: 14.00 vs. VFFVX (2.00). JFFIX has a lower initial minimum investment than VFFVX: JFFIX (0) vs VFFVX (1000). VFFVX annual gain was more profitable for investors over the last year : 22.45 vs. JFFIX (16.65). VFFVX return over 5 years is better than : 36.38 vs. JFFIX (21.85).
JFFIXVFFVXJFFIX / VFFVX
Total Expense Ratio0.490.08613%
Annual Report Gross Expense Ratio0.510.08638%
Fund Existence14 years16 years-
Gain YTD8.49610.27883%
Front LoadN/AN/A-
Min. Initial Investment01000-
Min. Initial Investment IRAN/AN/A-
Net Assets1.91B76.7B2%
Annual Yield % from dividends1.911.87102%
Returns for 1 year16.6522.4574%
Returns for 3 years53.8858.2193%
Returns for 5 years21.8536.3860%
Returns for 10 years105.20147.2971%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DD48.261.42
+3.03%
DuPont de Nemours
PACK7.300.16
+2.24%
Ranpak Holdings Corp
INBS2.400.01
+0.21%
Intelligent Bio Solutions Inc.
ITGR90.98-1.12
-1.22%
Integer Holdings Corp
ENGN1.62-0.02
-1.22%
enGene Therapeutics Inc